CLL-1/CD33 Targeted LCAR-AMDR Cells in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT05654779 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Both the sponsors and collaborator are considering terminating the study

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: LCAR-AMDR Cells Product

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]